American Healthcare REIT (AHR) Citi’s Miami Global Property CEO Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Citi’s Miami Global Property CEO Conference 2026 summary
29 Apr, 2026Market fundamentals and growth outlook
Senior housing and long-term care segments show strong supply-demand fundamentals, supporting robust organic earnings growth and favorable cost of capital, enabling external growth opportunities.
Guidance indicates nearly 18% NFFO per share growth at the midpoint, with a safe balance sheet at 3.4x net debt to EBITDA.
Sector benefits from demographic tailwinds, with 10,000 people turning 80 daily and limited new construction (less than 1% of stock under construction), supporting sustained growth.
Occupancy in RIDEA segments grew by 270-280 basis points last year, with continued demand expected as baby boomers age.
Revenue mix, reimbursement, and operator strategy
Trilogy segment leverages a mix of private pay, Medicare Advantage, and Medicaid, with private pay skilled nursing rates showing pricing power.
Trilogy partners selectively with Medicare Advantage plans offering the highest reimbursement, achieving over 8.5% growth in that business.
Shifting resident mix toward higher-reimbursement sources (Medicare, Medicare Advantage) is driving daily rate growth and reducing Medicaid exposure.
Trilogy’s integrated campus model (skilled nursing, assisted living, memory care, independent living) creates operational synergies and higher occupancy.
Operator selection, alignment, and scaling
Operator selection precedes real estate acquisition, with a rigorous, multi-year underwriting process focused on regional expertise and performance.
Management contracts with Trilogy are heavily incentive-based, aligned with EBITDA growth, and paid in stock, fostering strong operator alignment.
Trilogy’s scale and resources are leveraged to support regional operators, facilitating best practice sharing and helping them scale to meet projected demand shortfalls.
Latest events from American Healthcare REIT
- Q2 2026 saw double-digit NOI growth, raised guidance, and $1.4B in acquisitions closed.AHR
Q2 2026 - Strong demand, limited supply, and operator focus drive multi-year growth and raised 2025 guidance.AHR
Nareit REITweek: 2025 Investor Conference - Rapid growth, operator-focused acquisitions, and robust succession planning drive sector outperformance.AHR
Nareit REITweek: 2026 Investor Conference - Double-digit NOI and FFO growth drive raised 2026 guidance and strong Q1 results.AHR
Q1 2026 - Proxy covers director elections, auditor ratification, and strong 2025 performance with 80% TSR.AHR
Proxy filing - Double-digit NOI and NFFO growth in 2025, with strong 2026 outlook and robust acquisition pipeline.AHR
Q4 2025 - Q3 2025 net income hit $56.6M with 16.4% NOI growth and raised 2025 guidance.AHR
Q3 2025 - Trilogy buyout, strong NOI/FFO growth, and raised guidance mark a transformative Q3.AHR
Q3 2024 - Raised 2025 guidance after 15.1% same-store NOI growth and strong SHOP/ISHC performance.AHR
Q1 2025